 REHOVOT, Israel, March 29, 2021 PRNewswire -- CollPlant NASDAQ: CLGN, a regenerative and aesthetics medicine company, today announced the appointment of Hugh Evans to its Board of Directors, increasing the board to six independent members. U.S.-based Mr. 